Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Physiol
2017 Nov 15;59522:6993-7008. doi: 10.1113/JP275087.
Show Gene links
Show Anatomy links
Leukoencephalopathy-causing CLCN2 mutations are associated with impaired Cl- channel function and trafficking.
Gaitán-Peñas H
,
Apaja PM
,
Arnedo T
,
Castellanos A
,
Elorza-Vidal X
,
Soto D
,
Gasull X
,
Lukacs GL
,
Estévez R
.
???displayArticle.abstract???
KEY POINTS: Characterisation of most mutations found in CLCN2 in patients with CC2L leukodystrophy show that they cause a reduction in function of the chloride channel ClC-2. GlialCAM, a regulatory subunit of ClC-2 in glial cells and involved in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts (MLC), increases the activity of a ClC-2 mutant by affecting ClC-2 gating and by stabilising the mutant at the plasma membrane. The stabilisation of ClC-2 at the plasma membrane by GlialCAM depends on its localisation at cell-cell junctions. The membrane protein MLC1, which is defective in MLC, also contributes to the stabilisation of ClC-2 at the plasma membrane, providing further support for the view that GlialCAM, MLC1 and ClC-2 form a protein complex in glial cells.
ABSTRACT: Mutations in CLCN2 have been recently identified in patients suffering from a type of leukoencephalopathy involving intramyelinic oedema. Here, we characterised most of these mutations that reduce the function of the chloride channel ClC-2 and impair its plasma membrane (PM) expression. Detailed biochemical and electrophysiological analyses of the Ala500Val mutation revealed that defective gating and increased cellular and PM turnover contributed to defective A500V-ClC-2 functional expression. Co-expression of the adhesion molecule GlialCAM, which forms a tertiary complex with ClC-2 and megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1), rescued the functional expression of the mutant by modifying its gating properties. GlialCAM also restored the PM levels of the channel by impeding its turnover at the PM. This rescue required ClC-2 localisation to cell-cell junctions, since a GlialCAM mutant with compromised junctional localisation failed to rescue the impaired stability of mutant ClC-2 at the PM. Wild-type, but not mutant, ClC-2 was also stabilised by MLC1 overexpression. We suggest that leukodystrophy-causing CLCN2 mutations reduce the functional expression of ClC-2, which is partly counteracted by GlialCAM/MLC1-mediated increase in the gating and stability of the channel.
Adam,
CLCN2-Related Leukoencephalopathy
1993,
Pubmed
Alvarez,
Counting channels: a tutorial guide on ion channel fluctuation analysis.
2002,
Pubmed
Barrallo-Gimeno,
GlialCAM, a glial cell adhesion molecule implicated in neurological disease.
2014,
Pubmed
Barrallo-Gimeno,
Regulatory-auxiliary subunits of CLC chloride channel-transport proteins.
2015,
Pubmed
Biasini,
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.
2014,
Pubmed
Blanz,
Leukoencephalopathy upon disruption of the chloride channel ClC-2.
2007,
Pubmed
Bösl,
Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption.
2001,
Pubmed
Capdevila-Nortes,
Insights into MLC pathogenesis: GlialCAM is an MLC1 chaperone required for proper activation of volume-regulated anion currents.
2013,
Pubmed
Cornejo,
Rapid recycling of ClC-2 chloride channels between plasma membrane and endosomes: role of a tyrosine endocytosis motif in surface retrieval.
2009,
Pubmed
Depienne,
Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study.
2013,
Pubmed
Di Bella,
Subclinical leukodystrophy and infertility in a man with a novel homozygous CLCN2 mutation.
2014,
Pubmed
Duarri,
Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects.
2008,
Pubmed
,
Xenbase
Duarri,
Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model.
2011,
Pubmed
Estévez,
Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1.
2003,
Pubmed
,
Xenbase
Giorgio,
A novel homozygous change of CLCN2 (p.His590Pro) is associated with a subclinical form of leukoencephalopathy with ataxia (LKPAT).
2017,
Pubmed
Hanagasi,
Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation.
2015,
Pubmed
Hoegg-Beiler,
Disrupting MLC1 and GlialCAM and ClC-2 interactions in leukodystrophy entails glial chloride channel dysfunction.
2014,
Pubmed
Jentsch,
Discovery of CLC transport proteins: cloning, structure, function and pathophysiology.
2015,
Pubmed
Jeworutzki,
GlialCAM, a CLC-2 Cl(-) channel subunit, activates the slow gate of CLC chloride channels.
2014,
Pubmed
,
Xenbase
Jeworutzki,
GlialCAM, a protein defective in a leukodystrophy, serves as a ClC-2 Cl(-) channel auxiliary subunit.
2012,
Pubmed
,
Xenbase
Leegwater,
Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts.
2001,
Pubmed
López-Hernández,
Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts.
2011,
Pubmed
López-Hernández,
Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism.
2011,
Pubmed
Moh,
The immunoglobulin-like cell adhesion molecule hepaCAM modulates cell adhesion and motility through direct interaction with the actin cytoskeleton.
2009,
Pubmed
Pusch,
Low single channel conductance of the major skeletal muscle chloride channel, ClC-1.
1994,
Pubmed
,
Xenbase
Pérez-Rius,
Identification and characterization of the zebrafish ClC-2 chloride channel orthologs.
2015,
Pubmed
,
Xenbase
Scheper,
Analysis of CLCN2 as candidate gene for megalencephalic leukoencephalopathy with subcortical cysts.
2010,
Pubmed
,
Xenbase
Sirisi,
Depolarization causes the formation of a ternary complex between GlialCAM, MLC1 and ClC-2 in astrocytes: implications in megalencephalic leukoencephalopathy.
2017,
Pubmed
Zeydan,
Identification of 3 Novel Patients with CLCN2-Related Leukoencephalopathy due to CLCN2 Mutations.
2017,
Pubmed
Zúñiga,
The voltage-dependent ClC-2 chloride channel has a dual gating mechanism.
2004,
Pubmed
van der Knaap,
Megalencephalic leukoencephalopathy with subcortical cysts: chronic white matter oedema due to a defect in brain ion and water homoeostasis.
2012,
Pubmed